Efficacy Study of Acupuncture in the Prevention of Migraine Without Aura

W

Wei Wang

Status

Completed

Conditions

Migraine Without Aura

Treatments

Device: Sham acupuncture
Behavioral: Usual care
Device: Verum acupuncture

Study type

Interventional

Funder types

Other

Identifiers

NCT02765581
201403RCTMWA

Details and patient eligibility

About

Acupuncture is commonly used for the prevention of migraine, while the evidence for its efficacy is still uncertain. Current studies have not been able to determine whether the efficacy of acupuncture is due to the actual therapeutic effect of acupuncture, or a result of psychological benefits. To address this issue, we designed a clinical trial to evaluate the prophylactic efficacy of acupuncture for migraine without aura (MWoA). Furthermore, we will evaluate the impact of Chinese medicine factors and psychological factors on the efficacy of acupuncture.

Full description

This is a multicentre, stratified, randomized, sham-controlled clinical trial. 150 eligible participants will be randomly allocated into verum acupuncture, sham acupuncture, or usual care groups, in a 2:2:1 ratio. The verum acupuncture group will receive twenty verum acupuncture treatments over an eight-week period, while the sham acupuncture group will receive sham acupuncture treatments with non-penetrating needling. Participants assigned to the usual care group are scheduled to receive twenty verum acupuncture treatments for free after waiting 24 weeks. Health education will be provided to participants in the three groups. The primary outcomes will be the changes in the mean number of migraine days and migraine attacks per four-week cycle. The secondary outcomes will be as follows: the proportion of responders, migraine intensity, migraine disability assessment questionnaire, health-related and sleep-related quality of life, the dose of intake of acute medication. Chinese medicine factors will include de qi sensations and Traditional Chinese Medicine (TCM) constitution. Psychological outcomes will include anxiety, depression, personality, expectancy about acupuncture, and doctor-patient relationship. The central randomization and data collection will be conducted by an electronic data management system.

Enrollment

150 patients

Sex

All

Ages

15 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

1. Diagnosed as migraine without aura according to the International Classification of Headache Disorders,3rd edition beta version (ICHD-3β); 2. Aged between 15 and 65 years old, with initial onset of migraines before the age of 50 years; and 3. Experienced migraine attacks for at least 1 year; and 4. Experienced migraine attacks with 2-8 times per month during the last 3 months and baseline period, and the duration of migraine attacks lasting 4-72h without intake of acute drugs or at least 2h with intake of acute drugs; and 5. the mean headache Visual Analogue Scale (VAS) scores 4-8 at baseline; and 6. Had not taken any acupuncture treatment before study entry; and 7. Able to complete the baseline headache diary; and 8. Able to signing a informed consent.

Exclusion criteria

1. Tension-type headache, cluster headache, and other primary headache disorders, secondary headache disorders, neuralgia of the face or head; and 2. Combined with cardiovascular, liver, kidney, gastrointestinal tract, blood system and other serious primary diseases affecting the implementation of treatment programs, or combined with epilepsy, Parkinson or other nervous system diseases; and 3. Patients with severe mental illness, such as severe anxiety and depression; and 4. Pregnant women, women in lactation, and those planning to become pregnant; and 5. Participation in other clinical trials; and 6. Illiterate, or patients unable to read and understand scales; 7. Have experience of acupuncture.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

150 participants in 3 patient groups, including a placebo group

Verum acupuncture (VA)
Experimental group
Description:
Participants will be treated by verum acupuncture and usual care. They will be treated every other day to fulfill a 10-session treatment course, and another course will begin after resting 9 days. Each acupuncture treatment session for patients will be 30 minutes in duration.
Treatment:
Device: Verum acupuncture
Behavioral: Usual care
Sham acupuncture (SA)
Sham Comparator group
Description:
Participants will be treated by sham acupuncture and usual care. They will be treated every other day to fulfill a 10-session treatment course, and another course will begin after resting 9 days. Each acupuncture treatment session for patients will be 30 minutes in duration.
Treatment:
Behavioral: Usual care
Device: Sham acupuncture
Usual care (UA)
Placebo Comparator group
Description:
Participants will undergo a clinical interview once a month, complete the headache diary assessment, have counseling and health education, and rescue medication if necessary. In addition, they will be scheduled to receive 20 sessions of verum acupuncture treatments for free after a waiting period of 24 weeks.
Treatment:
Behavioral: Usual care

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems